The following figures show the history of Avastin (bevacizumab, anti-VEGF antibody)-related patents and biosimilar approval in Japan.
Figure 1: Avastin (bevacizumab, anti-VEGF antibody)-related patents in Japan
PDF view Figure 2: Avastin (bevacizumab)-related patents and Re-examination period in Japan
PDF view Figure 3: Pfizer's Avastin biosimilar approved in Japan
PDF view